Plasma Lipid Composition and Risk of Developing Cardiovascular Disease

• Celine Fernandez ,

  * E-mail: Celine.Fernandez@med.lu.se (CF); Olle.Melander@med.lu.se (OM)

  Affiliation Department of Clinical Sciences, Lund University, Malmö, Sweden

  ⨯
• Marianne Sandin,

  Affiliation Department of Immunotechnology, Lund University, Lund, Sweden

  ⨯
• Julio L. Sampaio,

  Affiliation Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany

  ⨯
• Peter Almgren,

  Affiliation Department of Clinical Sciences, Lund University, Malmö, Sweden

  ⨯
• Krzysztof Narkiewicz,

  Affiliation Department of Hypertension and Diabetology, Medical University of Gdansk, Gdansk, Poland

  ⨯
• Michal Hoffmann,

  Affiliation Department of Hypertension and Diabetology, Medical University of Gdansk, Gdansk, Poland

  ⨯
• Thomas Hedner,

  Affiliation Department of Medicine, Sahlgrenska Academy, Goteborg University, Goteborg, Sweden

  ⨯
• Björn Wahlstrand,

  Affiliation Department of Medicine, Sahlgrenska Academy, Goteborg University, Goteborg, Sweden

  ⨯
• Kai Simons,

  Affiliation Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany

  ⨯
• Andrej Shevchenko,

  Affiliation Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany

  ⨯
• Peter James,

  Affiliation Department of Immunotechnology, Lund University, Lund, Sweden

  ⨯
• Olle Melander

  * E-mail: Celine.Fernandez@med.lu.se (CF); Olle.Melander@med.lu.se (OM)

  Affiliation Department of Clinical Sciences, Lund University, Malmö, Sweden

  ⨯